DKK3 expression is associated with immunosuppression and poor prognosis in glioblastoma, in contrast to lower-grade gliomas

被引:0
|
作者
Myung-Hoon Han
Jeong Min Baek
Kyueng-Whan Min
Jin Hwan Cheong
Je Il Ryu
Yu Deok Won
Mi Jung Kwon
Seong-Ho Koh
机构
[1] Hanyang University Guri Hospital,Department of Neurosurgery
[2] Hanyang University College of Medicine,Department of Translational Medicine, Graduate School of Biomedical Science & Engineering
[3] Hanyang University,Department of Pathology Uijeongbu Eulji Medical Center
[4] Hanyang University,Department of Pathology
[5] Eulji University School of Medicine,Department of Neurology
[6] Hallym University Sacred Heart Hospital,undefined
[7] Hallym University College of Medicine,undefined
[8] Hanyang University Guri Hospital,undefined
来源
BMC Neurology | / 23卷
关键词
Glioblastoma multiforme; Lower grade glioma; Wnt/β-catenin signaling; Dickkopf-3; Survival; Disease progression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] A gene signature predicting prognosis of patients with lower-grade gliomas receiving temozolomide therapy
    Yanzhi Wan
    Guangqi Li
    Junyue Deng
    Hong Zhu
    Xuelei Ma
    Discover Oncology, 14
  • [32] Clinical characteristics and radiological features of glioblastoma, IDH-wildtype, grade 4 with histologically lower-grade gliomas
    Motomura, Kazuya
    Kibe, Yuji
    Ohka, Fumiharu
    Aoki, Kosuke
    Yamaguchi, Junya
    Saito, Ryuta
    BRAIN TUMOR PATHOLOGY, 2023, 40 (02) : 48 - 55
  • [33] Clinical characteristics and radiological features of glioblastoma, IDH-wildtype, grade 4 with histologically lower-grade gliomas
    Kazuya Motomura
    Yuji Kibe
    Fumiharu Ohka
    Kosuke Aoki
    Junya Yamaguchi
    Ryuta Saito
    Brain Tumor Pathology, 2023, 40 : 48 - 55
  • [34] PD-L1 tumor expression is associated with poor prognosis and systemic immunosuppression in glioblastoma
    Carolina Noronha
    Ana Sofia Ribeiro
    Ricardo Taipa
    Dina Leitão
    Fernando Schmitt
    Joaquim Reis
    Cláudia Faria
    Joana Paredes
    Journal of Neuro-Oncology, 2022, 156 : 453 - 464
  • [35] Clusterin Is a Prognostic Biomarker of Lower-Grade Gliomas and Is Associated with Immune Cell Infiltration
    Ren, Xiaoyue
    Chang, Chao
    Qi, Teng
    Yang, Pengyu
    Wang, Yuanbo
    Zhou, Xiaorui
    Guan, Feng
    Li, Xiang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [36] PD-L1 tumor expression is associated with poor prognosis and systemic immunosuppression in glioblastoma
    Noronha, Carolina
    Ribeiro, Ana Sofia
    Taipa, Ricardo
    Leitao, Dina
    Schmitt, Fernando
    Reis, Joaquim
    Faria, Claudia
    Paredes, Joana
    JOURNAL OF NEURO-ONCOLOGY, 2022, 156 (03) : 453 - 464
  • [37] Molecular and clinical characterization of IDH associated immune signature in lower-grade gliomas
    Qian, Zenghui
    Li, Yiming
    Fan, Xing
    Zhang, Chuanbao
    Wang, Yinyan
    Jiang, Tao
    Liu, Xing
    ONCOIMMUNOLOGY, 2018, 7 (06):
  • [38] Gene expression signature to predict radiation response in lower-grade gliomas.
    Qian, David C.
    Marascio, Joseph A.
    Neill, Stewart G.
    Hoang, Kimberly B.
    Olson, Jeffrey J.
    Eaton, Bree R.
    Shu, Hui-Kuo George
    Zhong, Jim
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [39] Publisher Correction: DNA demethylation is associated with malignant progression of lower-grade gliomas
    Masashi Nomura
    Kuniaki Saito
    Koki Aihara
    Genta Nagae
    Shogo Yamamoto
    Kenji Tatsuno
    Hiroki Ueda
    Shiro Fukuda
    Takayoshi Umeda
    Shota Tanaka
    Shunsaku Takayanagi
    Ryohei Otani
    Takahide Nejo
    Taijun Hana
    Satoshi Takahashi
    Yosuke Kitagawa
    Mayu Omata
    Fumi Higuchi
    Taishi Nakamura
    Yoshihiro Muragaki
    Yoshitaka Narita
    Motoo Nagane
    Ryo Nishikawa
    Keisuke Ueki
    Nobuhito Saito
    Hiroyuki Aburatani
    Akitake Mukasa
    Scientific Reports, 9
  • [40] Low GAS5 Levels as a Predictor of Poor Survival in Patients with Lower-Grade Gliomas
    Wang, Yanfang
    Xin, Shan
    Zhang, Kai
    Shi, Run
    Bao, Xuanwen
    JOURNAL OF ONCOLOGY, 2019, 2019